Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Escin

Home DrugsEscin

Experimental

Small Molecule

Escin

Unknown Manufacturer

Escin is an anti-inflammatory and vasoconstrictive agent indicated to treat minor muscle and joint trauma.

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Overview

Escin is an anti-inflammatory and vasoconstrictive agent indicated to treat minor muscle and joint trauma.

Associated Conditions

19 associated conditions

Search conditions

Concussion, Brain
Contusions
Inflammation
Inflammatory Reaction of the Lumbar Disc
Inflammatory Reaction of the Neck
Inflammatory Reaction of the Veins
Inflammatory Reaction of the spine
Lumbar Discogenic Pain (Disorder)
Myalgia
Neck Pain
Spinal pain
Swelling of the Leg

Technical identifiers

Chemical Formula: C₁₁₀H₁₇₂O₄₈
CAS Number: 6805-41-0
UNII ID: RUU8G67GQM